We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$169M
AUM Growth
-$15.1M
Cap. Flow
-$22.7M
Cap. Flow %
-13.45%
Top 10 Hldgs %
33.65%
Holding
197
New
30
Increased
43
Reduced
28
Closed
35

Sector Composition

Rank Sector Weight
1 Healthcare 15.95%
2 Technology 14.24%
3 Financials 7.09%
4 Industrials 3.96%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTST
151
NETSTREIT Corp
NTST
$2.07B
-7,211
Closed -$129K
NVS icon
152
CALL
Novartis
NVS
$291B
-10,900
Closed -$7.08K
OEF icon
153
CALL
iShares S&P 100 ETF
OEF
$20.1B
-124,800
Closed -$11.9K
QURE icon
154
CALL
uniQure
QURE
$2.99B
-54,600
Closed -$1.91K
RCUS icon
155
CALL
Arcus Biosciences
RCUS
$3.46B
-67,300
Closed -$133K
REXR icon
156
Rexford Industrial Realty
REXR
$8.35B
-5,789
Closed -$302K
SLNO
157
DELISTED
Soleno Therapeutics
SLNO
-90,858
Closed -$390K
SPG icon
158
Simon Property Group
SPG
$73.9B
-2,350
Closed -$271K
SQNS
159
Sequans Communications SA
SQNS
$37M
-2,611
Closed -$146K
VICI icon
160
VICI Properties
VICI
$28.9B
-18,098
Closed -$569K
VRE
161
DELISTED
Veris Residential
VRE
-11,733
Closed -$188K
AIRC
162
DELISTED
Apartment Income REIT Corp.
AIRC
-7,776
Closed -$281K
MDRX
163
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
-27,900
Closed -$6.28K
RVLP
164
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
-278,654
Closed -$156K
AMRS
165
PUT
DELISTED
Amyris Inc.
AMRS
-333,100
Closed -$159K
THER
166
DELISTED
THERATECHNOLOGIES INC COM
THER
-846,654
Closed -$713K

Similar funds

Worth Venture Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Worth Venture Partners held 197 positions worth $169M, down 8.2% from $184M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Worth Venture Partners withdrew a net $22.7M in Q3 2023, closing 35 positions and reducing 28 holdings. Its most notable exit was ANI Pharmaceuticals, an estimated $4.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Worth Venture Partners opened a new position in Aspen Aerogels worth $3.68M.

  • Worth Venture Partners's largest Q3 2023 buy was Aspen Aerogels: 428,367 shares worth $3.68M.
  • Worth Venture Partners added most to Vaccinex, Inc. Common Stock in Q3 2023, an estimated $2.57M increase.
  • Worth Venture Partners's biggest Q3 2023 reduction was Microchip Technology, cutting an estimated $5.37M.
  • Worth Venture Partners fully exited ANI Pharmaceuticals in Q3 2023, selling an estimated $4.71M.
  • Worth Venture Partners's ten largest holdings make up 34% of its $169M portfolio in Q3 2023.
  • Worth Venture Partners opened 30 new positions and closed 35 in Q3 2023.
  • Worth Venture Partners's portfolio value fell 8.2% quarter-over-quarter to $169M.

Based on Worth Venture Partners's 13F filing for Q3 2023, filed 15 Nov 2023.